The global prevalence of obesity has increased markedly, contributing to morbidities such as cardiovascular disease, type 2 diabetes, and obesity-related kidney disease. Chronic kidney disease (CKD) associated with obesity often progresses silently, making early diagnosis challenging. Traditional markers like the albumin-to-creatinine ratio (ACR) have limitations, highlighting the need for more sensitive biomarkers. Urinary neutrophil gelatinase-associated lipocalin (uNGAL) has emerged as a promising indicator of early renal injury. This study evaluated the uNGAL levels in 90 adult women stratified by body mass index (BMI) and waist-to-hip ratio (WHR) to assess their potential as a biomarker for obesity-associated kidney damage. Anthropometric measurements, including weight, height, waist circumference, and hip circumference, were obtained. Urine samples were analyzed for uNGAL using ELISA. Comparative and correlation analyses explored the associations between uNGAL and anthropometric variables. The results showed significantly higher uNGAL levels in obese participants and those classified as moderate- or high-risk by WHR compared to those in the controls (p < 0.05). Within the obese group, uNGAL correlated positively with BMI (r = 0.60) and weight (r = 0.52), while in the high-risk WHR group, positive correlations were found with weight (r = 0.54) and hip circumference (r = 0.50). These findings suggest that uNGAL may serve as an early, non-invasive biomarker for detecting subclinical kidney stress in women with obesity, particularly those with central adiposity.
Background/Objectives: Obesity is characterized by chronic low-grade inflammation and oxidative stress, mediated in part by Toll-like receptor (TLR)-associated pathways. Bariatric surgery improves clinical and metabolic parameters, but its effects on TLR-associated reactive oxygen species (ROS) responses in immune cells remain unclear. This study aimed to investigate ROS production following TLR2- and TLR4-associated stimulation in granulocytes from women with obesity before and after bariatric surgery, compared with age-matched non-obese controls. Methods: ROS production was evaluated using a luminol-dependent chemiluminescence assay in granulocytes isolated from women with obesity before (PRE, n = 12) and after (POST, n = 12) bariatric surgery, as well as from age-matched non-obese controls (n = 12). ROS production was assessed under basal conditions and following stimulation with lipopolysaccharide (LPS, a TLR4 agonist) or zymosan (ZY, a TLR2-associated stimulus). Clinical, anthropometric, and biochemical parameters were assessed, and their associations with ROS production were analyzed. Results: Bariatric surgery was associated with significant improvements in clinical and metabolic parameters, although mean BMI in the POST group remained within the obesity range. Granulocytes from the PRE group exhibited increased basal ROS production and enhanced responses following both LPS and ZY stimulation. In the POST group, basal ROS production and the response following ZY stimulation were comparable to those observed in controls, whereas LPS-associated ROS production remained elevated. Correlation analyses showed positive associations between anthropometric and biochemical parameters and ROS production in both PRE and POST groups, with body weight and BMI remaining positively associated with basal and LPS-associated ROS production after surgery. Conclusions: Bariatric surgery was associated with substantial clinical and metabolic improvement but did not completely restore innate immune redox homeostasis. The persistence of TLR4-driven ROS production suggests that some alterations in innate immune redox balance may persist after surgery despite metabolic improvement.